Source: Pharmacy Times articles
Saad Usmani, MD, MBA, FACP, FASCO, explores treatment duration, patient characteristics, and toxicity profiles in transplant-ineligible patients with newly diagnosed multiple myeloma.
Read More
by MM360 Staff | Jun 4, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Saad Usmani, MD, MBA, FACP, FASCO, explores treatment duration, patient characteristics, and toxicity profiles in transplant-ineligible patients with newly diagnosed multiple myeloma.
Read More